Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway

Abstract This study aimed to evaluate the therapeutic properties of the traditional Chinese medicine Xuesanqi (XSQ, from the rhizome of Polygonum amplexicaule D. Don) in treating ulcerative colitis. We hypothesized that its many active components can alleviate symptoms of colitis by regulating the g...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiyuan Su, Qian Hu, Songtao Wu, Suqin Yang, Hanwen Su, Zhengjun Zhang, Chengxiu Ling
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:Natural Products and Bioprospecting
Subjects:
Online Access:https://doi.org/10.1007/s13659-024-00482-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850107492679286784
author Qiyuan Su
Qian Hu
Songtao Wu
Suqin Yang
Hanwen Su
Zhengjun Zhang
Chengxiu Ling
author_facet Qiyuan Su
Qian Hu
Songtao Wu
Suqin Yang
Hanwen Su
Zhengjun Zhang
Chengxiu Ling
author_sort Qiyuan Su
collection DOAJ
description Abstract This study aimed to evaluate the therapeutic properties of the traditional Chinese medicine Xuesanqi (XSQ, from the rhizome of Polygonum amplexicaule D. Don) in treating ulcerative colitis. We hypothesized that its many active components can alleviate symptoms of colitis by regulating the gut microbiota, its metabolites, and various signaling pathways. To test our hypotheses, we designed a DSS- induced colitis model in C57BL/6 male mice. Apparent metrics were evaluated in each group of mice and performed histological analysis of relevant tissues. The gut microbial composition was analyzed by 16S rRNA sequencing of bacteria. Simultaneously, the SCFAs content was detected by gas chromatography, inflammatory factor secretion was evaluated by ELISA or western-blot, the expression of tight junction protein and key proteins of the MAPK signaling pathway were analyzed by western-blot. Our result showed that the treatment with XSQ alleviated significant various symptoms such as weight loss, blood in stool, and shortening of colon. In addition, XSQ treatment restored the dysregulated gut microbiota in colitis mice, increased short chain fatty acids (SCFAs) and normalized the MAPK/ERK/JNK signaling pathways, promoted expression of tight junction protein Occludin, Claudin-1, and E-cadherin proteins. Furthermore, we also observed a dose-dependent pattern in these treatment responses. These findings demonstrated the active components of XSQ is a promising new treatment platform for ulcerative colitis. Graphical Abstract
format Article
id doaj-art-573ecd3313ac48e9b66baf1b91edb7f2
institution OA Journals
issn 2192-2195
2192-2209
language English
publishDate 2024-12-01
publisher SpringerOpen
record_format Article
series Natural Products and Bioprospecting
spelling doaj-art-573ecd3313ac48e9b66baf1b91edb7f22025-08-20T02:38:35ZengSpringerOpenNatural Products and Bioprospecting2192-21952192-22092024-12-0114111710.1007/s13659-024-00482-8Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathwayQiyuan Su0Qian Hu1Songtao Wu2Suqin Yang3Hanwen Su4Zhengjun Zhang5Chengxiu Ling6Wisdom Lake Academy of Pharmacy, Xi’an Jiaotong-Liverpool UniversityWuhan Children’s Hospital, Tongji Medical College, Huazhong University of Science and TechnologyFaculty of Pharmacy, Hubei University of Chinese MedicineSchool of Pharmaceutical Sciences, South-Central Minzu UniversityDepartment of Clinical Laboratory, Renmin Hospital of Wuhan UniversityDepartment of Statistics, University of Wisconsin-MadisonWisdom Lake Academy of Pharmacy, Xi’an Jiaotong-Liverpool UniversityAbstract This study aimed to evaluate the therapeutic properties of the traditional Chinese medicine Xuesanqi (XSQ, from the rhizome of Polygonum amplexicaule D. Don) in treating ulcerative colitis. We hypothesized that its many active components can alleviate symptoms of colitis by regulating the gut microbiota, its metabolites, and various signaling pathways. To test our hypotheses, we designed a DSS- induced colitis model in C57BL/6 male mice. Apparent metrics were evaluated in each group of mice and performed histological analysis of relevant tissues. The gut microbial composition was analyzed by 16S rRNA sequencing of bacteria. Simultaneously, the SCFAs content was detected by gas chromatography, inflammatory factor secretion was evaluated by ELISA or western-blot, the expression of tight junction protein and key proteins of the MAPK signaling pathway were analyzed by western-blot. Our result showed that the treatment with XSQ alleviated significant various symptoms such as weight loss, blood in stool, and shortening of colon. In addition, XSQ treatment restored the dysregulated gut microbiota in colitis mice, increased short chain fatty acids (SCFAs) and normalized the MAPK/ERK/JNK signaling pathways, promoted expression of tight junction protein Occludin, Claudin-1, and E-cadherin proteins. Furthermore, we also observed a dose-dependent pattern in these treatment responses. These findings demonstrated the active components of XSQ is a promising new treatment platform for ulcerative colitis. Graphical Abstracthttps://doi.org/10.1007/s13659-024-00482-8ColitisXuesanqiGut microbiotaShort chain fatty acids (SCFas)MAPK/ERK/JNK signaling pathwayTight junction (T.J.) protein
spellingShingle Qiyuan Su
Qian Hu
Songtao Wu
Suqin Yang
Hanwen Su
Zhengjun Zhang
Chengxiu Ling
Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
Natural Products and Bioprospecting
Colitis
Xuesanqi
Gut microbiota
Short chain fatty acids (SCFas)
MAPK/ERK/JNK signaling pathway
Tight junction (T.J.) protein
title Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
title_full Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
title_fullStr Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
title_full_unstemmed Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
title_short Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
title_sort xuesanqi ameliorates dss induced colitis in mice by mediating gut microbiota dysbiosis and modulating mapk erk jnk pathway
topic Colitis
Xuesanqi
Gut microbiota
Short chain fatty acids (SCFas)
MAPK/ERK/JNK signaling pathway
Tight junction (T.J.) protein
url https://doi.org/10.1007/s13659-024-00482-8
work_keys_str_mv AT qiyuansu xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway
AT qianhu xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway
AT songtaowu xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway
AT suqinyang xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway
AT hanwensu xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway
AT zhengjunzhang xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway
AT chengxiuling xuesanqiamelioratesdssinducedcolitisinmicebymediatinggutmicrobiotadysbiosisandmodulatingmapkerkjnkpathway